medroxalol

This page covers all medroxalol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-1A adrenergic receptor, Beta-1 adrenergic receptor.

Targets

Alpha-1A adrenergic receptor, Beta-1 adrenergic receptor

Phase 2 pipeline (1)

• MEDROXALOL · Cardiovascular
  Medroxalol blocks the beta-1 adrenergic receptor to decrease heart rate and blood pressure.

Patent intelligence

• medroxalol patent landscape — aggregated cliff calendar, attackable patents, originator estates